Cancer Institute Hospital of JFCR

The Cancer Institute Hospital of JFCR, the Japanese Foundation for Cancer Research in Tokyo, is Japan's oldest cancer institute, founded in 1908, and ranks twenty-fifth in the Newsweek/Statista oncology list. It is strong in gastric cancer surgery, breast oncology and antibody-drug conjugate trials, and genomic medicine, with Takeshi Sano, Shinji Ohno, Takayuki Ueno and Shunji Takahashi among the clinicians OnCo lists. OnCo links it to gastric and gastro-oesophageal junction cancer, to the Japanese Society of Medical Oncology and Japanese oncology guidelines, and to the idea of active surveillance as the default for tiny papillary thyroid cancers. How far Japanese surgical standards for gastric cancer transfer to lower-incidence countries remains debated. Its gastric and breast programmes are the ones to follow.